J-LSMS | Research | SARS-CoV-2

18. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol . 2018;72(18):2231-2264. doi:10.1016/j.jacc.2018.08.1038 19. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) [published correction appears in JAMA Cardiol. 2020 Jul 1;5(7):848]. JAMA Cardiol . 2020;5(7):811-818. doi:10.1001/jamacardio.2020.1017 20. Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China [published correction appears in Intensive Care Med. 2020 Apr 6;:]. Intensive Care Med . 2020;46(5):846-848. doi:10.1007/s00134-020-05991-x 21. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol . 2020;5(7):802-810. doi:10.1001/ jamacardio.2020.0950 22. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. JAMA Cardiol . 2020;5(7):831-840. doi:10.1001/ jamacardio.2020.1286 23. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol . 2020;17(5):259-260. doi:10.1038/s41569-020-0360-5 24. Madjid M, Aboshady I, Awan I, Litovsky S, Casscells SW. Influenza and cardiovascular disease: is there a causal relationship?. Tex Heart Inst J . 2004;31(1):4-13. 25. Kwong JC, Schwartz KL, Campitelli MA, et al. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med . 2018;378(4):345-353. doi:10.1056/ NEJMoa1702090 26. Peiris JS, Chu CM, Cheng VC, et al. Clinical progression and viral load in a community outbreak of coronavirus- associated SARS pneumonia: a prospective study. Lancet . 2003;361(9371):1767-1772. doi:10.1016/s0140-6736(03)13412-5 27. Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19 - A Case Series. N Engl J Med . 2020;382(25):2478-2480. doi:10.1056/NEJMc2009020 28. Stefanini GG, Montorfano M, Trabattoni D, et al. ST-Elevation Myocardial Infarction in Patients With COVID-19: Clinical and Angiographic Outcomes. Circulation . 2020;141(25):2113-2116. doi:10.1161/CIRCULATIONAHA.120.047525 29. Pessoa-Amorim G, Camm CF, Gajendragadkar P, et al. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology. Eur Heart J Qual Care Clin Outcomes . 2020;6(3):210- 216. doi:10.1093/ehjqcco/qcaa046 30. Katz JN, Sinha SS, Alviar CL, et al. COVID-19 and Disruptive Modifications to Cardiac Critical Care Delivery: JACC Review Topic of the Week. J Am Coll Cardiol . 2020;76(1):72-84. doi:10.1016/j.jacc.2020.04.029

SARS pathogenesis. J Pathol . 2004;203(2):631-637. doi:10.1002/ path.1570 4. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS- CoV-2 Associated with the COVID-19 Outbreak [published correction appears in Curr Biol. 2020 Apr 20;30(8):1578]. Curr Biol . 2020;30(7):1346-1351.e2. doi:10.1016/j.cub.2020.03.022 5. Clerkin KJ, Fried JA, Raikhelkar J, et al. COVID-19 and Cardiovascular Disease. Circulation . 2020;141(20):1648-1655. doi:10.1161/CIRCULATIONAHA.120.046941 6. Lauer SA, Grantz KH, Bi Q, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med . 2020;172(9):577-582. doi:10.7326/M20-0504 7. Liu B, Li M, Zhou Z, Guan X, Xiang Y. Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)- induced cytokine release syndrome (CRS)?. J Autoimmun . 2020;111:102452. doi:10.1016/j.jaut.2020.102452 8. Steinberg BE, Goldenberg NM, Lee WL. Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods. Antiviral Res . 2012;93(1):2-15. doi:10.1016/j.antiviral.2011.10.019 9. Unudurthi SD, Luthra P, Bose RJC, McCarthy JR, Kontaridis MI. Cardiac inflammation in COVID-19: Lessons from heart failure. Life Sci . 2020;260:118482. doi:10.1016/j.lfs.2020.118482 10. Siripanthong B, Nazarian S, Muser D, et al. Recognizing COVID-19-related myocarditis: The possible pathophysiology and proposed guideline for diagnosis and management. Heart Rhythm . 2020;17(9):1463-1471. doi:10.1016/j.hrthm.2020.05.001 11. Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clin Chim Acta . 2020;506:145-148. doi:10.1016/j.cca.2020.03.022 12. Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail . 2020;22(5):911-915. doi:10.1002/ejhf.1828 13. Dolhnikoff M, Ferreira Ferranti J, de Almeida Monteiro RA, et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-

related multisystem inflammatory syndrome [published correction appears in Lancet Child Adolesc Health. 2020 Oct;4(10):e39]. Lancet Child Adolesc Health . 2020;4(10):790-794. doi:10.1016/S2352-4642(20)30257-1 14. Carsana L, Sonzogni A, Nasr A, et al. Pulmonary post- mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis . 2020;20(10):1135-1140. doi:10.1016/S1473-3099(20)30434-5 15. Blasco A, Coronado MJ, Hernández-Terciado F, et al. Assessment of Neutrophil Extracellular Traps in Coronary Thrombus of a Case Series of Patients With COVID-19 and Myocardial Infarction [published online ahead of print, 2020 Dec 29]. JAMA Cardiol . 2020;e207308. doi:10.1001/ jamacardio.2020.7308 16. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med . 2020;46(6):1089- 1098. doi:10.1007/s00134-020-06062-x 17. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med . 2020;382(17):e38. doi:10.1056/NEJMc2007575

31. Mahmud E, Dauerman HL, Welt FGP, et al. Management of acute myocardial infarction during the COVID-19 pandemic: A Consensus Statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv . 2020;96(2):336- 345. doi:10.1002/ccd.28946 32. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: 28

Made with FlippingBook Digital Publishing Software